- Home
- CHNR vs CNSP Comparison
CHNR vs CNSP Comparison
Compare CHNR & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHNR
- CNSP
- Stock Information
- Founded
- CHNR N/A
- CNSP 2017
- Country
- CHNR Hong Kong
- CNSP United States
- Employees
- CHNR N/A
- CNSP N/A
- Industry
- CHNR Precious Metals
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- CHNR Basic Materials
- CNSP Health Care
- Exchange
- CHNR Nasdaq
- CNSP Nasdaq
- Market Cap
- CHNR 5.2M
- CNSP 5.6M
- IPO Year
- CHNR 1995
- CNSP 2019
- Fundamental
- Price
- CHNR $0.56
- CNSP $1.28
- Analyst Decision
- CHNR
- CNSP Hold
- Analyst Count
- CHNR 0
- CNSP 1
- Target Price
- CHNR N/A
- CNSP N/A
- AVG Volume (30 Days)
- CHNR 50.3K
- CNSP 4.8M
- Earning Date
- CHNR 05-15-2025
- CNSP 05-16-2025
- Dividend Yield
- CHNR N/A
- CNSP N/A
- EPS Growth
- CHNR N/A
- CNSP N/A
- EPS
- CHNR N/A
- CNSP N/A
- Revenue
- CHNR N/A
- CNSP N/A
- Revenue This Year
- CHNR N/A
- CNSP N/A
- Revenue Next Year
- CHNR N/A
- CNSP N/A
- P/E Ratio
- CHNR N/A
- CNSP N/A
- Revenue Growth
- CHNR N/A
- CNSP N/A
- 52 Week Low
- CHNR $0.45
- CNSP $0.77
- 52 Week High
- CHNR $1.13
- CNSP $800.00
- Technical
- Relative Strength Index (RSI)
- CHNR 52.58
- CNSP 49.89
- Support Level
- CHNR $0.51
- CNSP $1.06
- Resistance Level
- CHNR $0.66
- CNSP $2.90
- Average True Range (ATR)
- CHNR 0.05
- CNSP 0.21
- MACD
- CHNR 0.00
- CNSP 0.07
- Stochastic Oscillator
- CHNR 35.87
- CNSP 15.27
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.